Clinical prolife and outcome in COVID-19 patients on treatment regimen of remdesivir, favipiravir, and non-antiviral drugs
Background: Although various drugs have been used in the treatment of COVID-19 infections, specific drug with good therapeutic outcome is still unclear. They are using remdesivir, favipiravir, ivermectin, azithromycin, and so on. Aim and Objectives: This study aimed to evaluate the clinical profile...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Eldaghayes Publisher
2023-07-01
|
| Saila: | National Journal of Physiology, Pharmacy and Pharmacology |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.ejmanager.com/fulltextpdf.php?mno=153039 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|